MRNA PDUFA decision: Wednesday, August 5, 2026

…review in Europe, Canada and Australia and potential approvals are expected to begin in 2026. The U.S. FDA has assigned a PDUFA date for mRNA-1010 of August 5, 2026. • Norovirus vaccine : Moderna's Phase 3 safety and efficacy study of mRNA-1403 did not meet statistical criteria for early

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.